Jardiance drug searches spike 50% amid Usain Bolt campaign

The makers of the chronic kidney disease (CKD) drug Jardiance say that enlisting retired sprinter Usain Bolt as the face of their latest campaign has raised awareness, amid a spike in online searches. The campaign draws on the contrast between Bolt’s reputation as the world’s fastest man and Jardiance’s message about slowing the progression of kidney disease. The drug is co-owned by German pharmaceutical company Boehringer Ingelheim and American drugmaker Eli Lilly.